BALCHEM CORP Passive Investment Disclosure (>5%)
Balchem Corp ownership disclosure: Vanguard Portfolio Management reports beneficial ownership of 2,221,969 shares of Common Stock, representing 6.93% of the class as of 03/31/2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Balchem Corp ownership disclosure: Vanguard Portfolio Management reports beneficial ownership of 2,221,969 shares of Common Stock, representing 6.93% of the class as of 03/31/2026. The filing states Vanguard has sole dispositive power over 2,221,969 shares and sole voting power for 28,552 shares. The disclosure attributes holdings to Vanguard Portfolio Management LLC and affiliates and is signed by a Vanguard officer on 04/28/2026.
Insights
Vanguard holds a sizable passive stake in Balchem, disclosed via Schedule 13G.
Vanguard Portfolio Management reports beneficial ownership of 2,221,969 shares or 6.93% as of 03/31/2026. The filing characterizes the position as exercised through Vanguard Portfolio Management LLC and named affiliates.
Because this is a Section 13G passive ownership filing, it signals institutional scale but not an activist intent; cash‑flow treatment and trading plans are not described in the excerpt, so future trading activity depends on Vanguard and its clients.
AI-generated analysis. How Rhea-AI works. Not financial advice.